{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T17:16:00Z","timestamp":1794503760788,"version":"4.9.1"},"reference-count":90,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,7,5]],"date-time":"2022-07-05T00:00:00Z","timestamp":1656979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,7,5]],"date-time":"2022-07-05T00:00:00Z","timestamp":1656979200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100019533","name":"Moderna, Inc.","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100019533","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Interleukin-2 (IL-2) is critical for regulatory T cell (Treg) function and homeostasis. At low doses, IL-2 can suppress immune pathologies by expanding Tregs that constitutively express the high affinity IL-2R\u03b1 subunit. However, even low dose IL-2, signaling through the IL2-R\u03b2\/\u03b3 complex, may lead to the activation of proinflammatory, non-Treg T cells, so improving specificity toward Tregs may be desirable. Here we use messenger RNAs (mRNA) to encode a half-life-extended human IL-2 mutein (HSA-IL2m) with mutations promoting reliance on IL-2R\u03b1. Our data show that IL-2 mutein subcutaneous delivery as lipid-encapsulated mRNA nanoparticles selectively activates and expands Tregs in mice and non-human primates, and also reduces disease severity in mouse models of acute graft versus host disease and experimental autoimmune encephalomyelitis. Single cell RNA-sequencing of mouse splenic CD4\n                    <jats:sup>+<\/jats:sup>\n                    T cells identifies multiple Treg states with distinct response dynamics following IL-2 mutein treatment. Our results thus demonstrate the potential of mRNA-encoded HSA-IL2m immunotherapy to treat autoimmune diseases.\n                  <\/jats:p>","DOI":"10.1038\/s41467-022-31130-9","type":"journal-article","created":{"date-parts":[[2022,7,5]],"date-time":"2022-07-05T06:03:02Z","timestamp":1657000982000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":62,"title":["Selective activation and expansion of regulatory T cells using lipid encapsulated mRNA encoding a long-acting IL-2 mutein"],"prefix":"10.1038","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4945-6653","authenticated-orcid":false,"given":"Seymour","family":"de Picciotto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"DeVita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8961-7522","authenticated-orcid":false,"given":"Chiaowen Joyce","family":"Hsiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Honan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sze-Wah","family":"Tse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mychael","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph D.","family":"Ferrari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian T.","family":"Wipke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,7,5]]},"reference":[{"key":"31130_CR1","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1038\/302305a0","volume":"302","author":"T Taniguchi","year":"1983","unstructured":"Taniguchi, T. et al. Structure and expression of a cloned cDNA for human interleukin-2. Nature 302, 305\u2013310 (1983).","journal-title":"Nature"},{"key":"31130_CR2","doi-asserted-by":"publisher","first-page":"5451","DOI":"10.4049\/jimmunol.1490019","volume":"192","author":"SA Rosenberg","year":"2014","unstructured":"Rosenberg, S. A. IL-2: The first effective immunotherapy for human cancer. J. Immunol. 192, 5451\u20135458 (2014).","journal-title":"J. Immunol."},{"key":"31130_CR3","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.1126\/science.7770771","volume":"268","author":"H Suzuki","year":"1995","unstructured":"Suzuki, H. et al. Deregulated T cell activation and autoimmunity in mice lacking interleukin-2 receptor beta. Science 268, 1472\u20131476 (1995).","journal-title":"Science"},{"key":"31130_CR4","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/1074-7613(95)90180-9","volume":"3","author":"DM Willerford","year":"1995","unstructured":"Willerford, D. M. et al. Interleukin-2 receptor \u03b1 chain regulates the size and content of the peripheral lymphoid compartment. Immunity 3, 521\u2013530 (1995).","journal-title":"Immunity"},{"key":"31130_CR5","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1093\/intimm\/dxn044","volume":"20","author":"M Bonelli","year":"2008","unstructured":"Bonelli, M. et al. Quantitative and qualitative deficiencies of regulatory T cells in patients with systemic lupus erythematosus (SLE). Int. Immunol. 20, 861\u2013868 (2008).","journal-title":"Int. Immunol."},{"key":"31130_CR6","doi-asserted-by":"publisher","first-page":"2084","DOI":"10.1093\/rheumatology\/keq237","volume":"49","author":"JAG Roon","year":"2010","unstructured":"Roon, J. A. G., van, Hartgring, S. A. Y., Wurff-Jacobs, K. M. G., van der, Bijlsma, J. W. J. & Lafeber, F. P. J. G. Numbers of CD25+Foxp3+ T cells that lack the IL-7 receptor are increased intra-articularly and have impaired suppressive function in RA patients. Rheumatology 49, 2084\u20132089 (2010).","journal-title":"Rheumatology"},{"key":"31130_CR7","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1111\/cei.12116","volume":"173","author":"F Haseda","year":"2013","unstructured":"Haseda, F., Imagawa, A., Murase-Mishiba, Y., Terasaki, J. & Hanafusa, T. CD4+CD45RA\u2212FoxP3high activated regulatory T cells are functionally impaired and related to residual insulin-secreting capacity in patients with type 1 diabetes: Functionally impaired a-Tregs in T1D. Clin. Exp. Immunol. 173, 207\u2013216 (2013).","journal-title":"Clin. Exp. Immunol."},{"key":"31130_CR8","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.2337\/diabetes.54.5.1407","volume":"54","author":"TM Brusko","year":"2005","unstructured":"Brusko, T. M., Wasserfall, C. H., Clare-Salzler, M. J., Schatz, D. A. & Atkinson, M. A. Functional defects and the influence of age on the frequency of CD4+CD25+ T-cells in type 1. Diabetes 54, 1407\u20131414 (2005).","journal-title":"Diabetes"},{"key":"31130_CR9","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1016\/j.autrev.2011.05.004","volume":"10","author":"M Miyara","year":"2011","unstructured":"Miyara, M. et al. Human FoxP3+ regulatory T cells in systemic autoimmune diseases. Autoimmun. Rev. 10, 744\u2013755 (2011).","journal-title":"Autoimmun. Rev."},{"key":"31130_CR10","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/j.immuni.2019.01.020","volume":"50","author":"JB Wing","year":"2019","unstructured":"Wing, J. B., Tanaka, A. & Sakaguchi, S. Human FOXP3+ regulatory T cell heterogeneity and function in autoimmunity and cancer. Immunity 50, 302\u2013316 (2019).","journal-title":"Immunity"},{"key":"31130_CR11","first-page":"315ra189","volume":"7","author":"JA Bluestone","year":"2015","unstructured":"Bluestone, J. A. et al. Type 1 diabetes immunotherapy using polyclonal regulatory T cells. Sci. Transl. Med. 7, 315ra189\u2013315ra189 (2015).","journal-title":"Sci. Transl. Med."},{"key":"31130_CR12","doi-asserted-by":"publisher","first-page":"43","DOI":"10.3389\/fimmu.2019.00043","volume":"10","author":"M Romano","year":"2019","unstructured":"Romano, M., Fanelli, G., Albany, C. J., Giganti, G. & Lombardi, G. Past, present, and future of regulatory T cell therapy in transplantation and autoimmunity. Front. Immunol. 10, 43 (2019).","journal-title":"Front. Immunol."},{"key":"31130_CR13","doi-asserted-by":"publisher","first-page":"2055","DOI":"10.1056\/NEJMoa1108188","volume":"365","author":"J Koreth","year":"2011","unstructured":"Koreth, J. et al. Interleukin-2 and regulatory T cells in graft-versus-host disease. N. Engl. J. Med. 365, 2055\u20132066 (2011).","journal-title":"N. Engl. J. Med."},{"key":"31130_CR14","doi-asserted-by":"publisher","first-page":"e44","DOI":"10.1016\/S2665-9913(19)30018-9","volume":"1","author":"JY Humrich","year":"2019","unstructured":"Humrich, J. Y. et al. Low-dose interleukin-2 therapy in refractory systemic lupus erythematosus: An investigator-initiated, single-centre phase 1 and 2a clinical trial. Lancet Rheumatol. 1, e44\u2013e54 (2019).","journal-title":"Lancet Rheumatol."},{"key":"31130_CR15","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1136\/annrheumdis-2018-214229","volume":"78","author":"M Rosenzwajg","year":"2019","unstructured":"Rosenzwajg, M. et al. Immunological and clinical effects of low-dose interleukin-2 across 11 autoimmune diseases in a single, open clinical trial. Ann. Rheum. Dis. 78, 209 (2019).","journal-title":"Ann. Rheum. Dis."},{"key":"31130_CR16","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/S2213-8587(13)70113-X","volume":"1","author":"A Hartemann","year":"2013","unstructured":"Hartemann, A. et al. Low-dose interleukin 2 in patients with type 1 diabetes: a phase 1\/2 randomised, double-blind, placebo-controlled trial. Lancet Diabetes Endocrinol. 1, 295\u2013305 (2013).","journal-title":"Lancet Diabetes Endocrinol."},{"key":"31130_CR17","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1001\/jamadermatol.2014.504","volume":"150","author":"E Castela","year":"2014","unstructured":"Castela, E. et al. Effects of low-dose recombinant interleukin 2 to promote T-regulatory cells in alopecia areata. JAMA Dermatol. 150, 748\u2013751 (2014).","journal-title":"JAMA Dermatol."},{"key":"31130_CR18","doi-asserted-by":"publisher","first-page":"2067","DOI":"10.1056\/NEJMoa1105143","volume":"365","author":"D Saadoun","year":"2011","unstructured":"Saadoun, D. et al. Regulatory T-cell responses to low-dose interleukin-2 in HCV-induced vasculitis. N. Engl. J. Med. 365, 2067\u20132077 (2011).","journal-title":"N. Engl. J. Med."},{"key":"31130_CR19","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1182\/blood-2016-02-702852","volume":"128","author":"J Koreth","year":"2016","unstructured":"Koreth, J. et al. Efficacy, durability, and response predictors of low-dose interleukin-2 therapy for chronic graft-versus-host disease. Blood 128, 130\u2013137 (2016).","journal-title":"Blood"},{"key":"31130_CR20","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1038\/sj.bmt.1705661","volume":"39","author":"ST Kim","year":"2007","unstructured":"Kim, S. T. et al. New clinical grading system for chronic GVHD predicts duration of systemic immunosuppressive treatment and GVHD-specific and overall survival. Bone Marrow Transpl. 39, 711\u2013716 (2007).","journal-title":"Bone Marrow Transpl."},{"key":"31130_CR21","first-page":"2009","volume":"50","author":"MW Konrad","year":"1990","unstructured":"Konrad, M. W. et al. Pharmacokinetics of recombinant interleukin 2 in humans. Cancer Res. 50, 2009\u20132017 (1990).","journal-title":"Cancer Res."},{"key":"31130_CR22","doi-asserted-by":"publisher","first-page":"1924","DOI":"10.1126\/science.1122927","volume":"311","author":"O Boyman","year":"2006","unstructured":"Boyman, O., Kovar, M., Rubinstein, M. P., Surh, C. D. & Sprent, J. Selective stimulation of T cell subsets with antibody-cytokine immune complexes. Science 311, 1924\u20131927 (2006).","journal-title":"Science"},{"key":"31130_CR23","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1038\/s41591-018-0070-2","volume":"24","author":"E Trotta","year":"2018","unstructured":"Trotta, E. et al. A human anti-IL-2 antibody that potentiates regulatory T cells by a structure-based mechanism. Nat. Med. 24, 1005\u20131014 (2018).","journal-title":"Nat. Med."},{"key":"31130_CR24","doi-asserted-by":"publisher","first-page":"13349","DOI":"10.1074\/jbc.271.23.13349","volume":"271","author":"DZ Chang","year":"1996","unstructured":"Chang, D. Z., Wu, Z. & Ciardelli, T. L. A point mutation in interleukin-2 that alters ligand internalization. J. Biol. Chem. 271, 13349\u201313355 (1996).","journal-title":"J. Biol. Chem."},{"key":"31130_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2018.10.017","author":"LB Peterson","year":"2018","unstructured":"Peterson, L. B. et al. A long-lived IL-2 mutein that selectively activates and expands regulatory T cells as a therapy for autoimmune disease. J. Autoimmun. https:\/\/doi.org\/10.1016\/j.jaut.2018.10.017 (2018).","journal-title":"J. Autoimmun."},{"key":"31130_CR26","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1038\/s41586-018-0830-7","volume":"565","author":"D-A Silva","year":"2019","unstructured":"Silva, D.-A. et al. De novo design of potent and selective mimics of IL-2 and IL-15. Nature 565, 186\u2013191 (2019).","journal-title":"Nature"},{"key":"31130_CR27","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1016\/j.immuni.2015.04.015","volume":"42","author":"JB Spangler","year":"2015","unstructured":"Spangler, J. B. et al. Antibodies to interleukin-2 elicit selective T cell subset potentiation through distinct conformational mechanisms. Immunity 42, 815\u2013825 (2015).","journal-title":"Immunity"},{"key":"31130_CR28","doi-asserted-by":"publisher","first-page":"120786","DOI":"10.1016\/j.biomaterials.2021.120786","volume":"272","author":"KE Olson","year":"2021","unstructured":"Olson, K. E. et al. Granulocyte-macrophage colony-stimulating factor mRNA and Neuroprotective Immunity in Parkinson\u2019s disease. Biomaterials 272, 120786 (2021).","journal-title":"Biomaterials"},{"key":"31130_CR29","doi-asserted-by":"publisher","first-page":"eaat9143","DOI":"10.1126\/scitranslmed.aat9143","volume":"11","author":"SL Hewitt","year":"2019","unstructured":"Hewitt, S. L. et al. Durable anticancer immunity from intratumoral administration of IL-23, IL-36\u03b3, and OX40L mRNAs. Sci. Transl. Med. 11, eaat9143 (2019).","journal-title":"Sci. Transl. Med."},{"key":"31130_CR30","doi-asserted-by":"crossref","unstructured":"August, A. et al. A phase 1 trial of lipid-encapsulated mRNA encoding a monoclonal antibody with neutralizing activity against Chikungunya virus. Nat. Med. 27, 2224\u20132233 (2021).","DOI":"10.1038\/s41591-021-01573-6"},{"key":"31130_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-08852-4","volume":"10","author":"L-M Gan","year":"2019","unstructured":"Gan, L.-M. et al. Intradermal delivery of modified mRNA encoding VEGF-A in patients with type 2 diabetes. Nat. Commun. 10, 871 (2019).","journal-title":"Nat. Commun."},{"key":"31130_CR32","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1038\/s41590-018-0051-0","volume":"19","author":"D Zemmour","year":"2018","unstructured":"Zemmour, D. et al. Single-cell gene expression reveals a landscape of regulatory T cell phenotypes shaped by the TCR. Nat. Immunol. 19, 291\u2013301 (2018).","journal-title":"Nat. Immunol."},{"key":"31130_CR33","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/j.immuni.2019.01.001","volume":"50","author":"RJ Miragaia","year":"2019","unstructured":"Miragaia, R. J. et al. Single-cell transcriptomics of regulatory T cells reveals trajectories of tissue adaptation. Immunity 50, 493\u2013504.e7 (2019).","journal-title":"Immunity"},{"key":"31130_CR34","doi-asserted-by":"publisher","first-page":"e1006599","DOI":"10.1371\/journal.pgen.1006599","volume":"13","author":"KK Dey","year":"2017","unstructured":"Dey, K. K., Hsiao, C. J. & Stephens, M. Visualizing the structure of RNA-seq expression data using grade of membership models. PLoS Genet. 13, e1006599 (2017).","journal-title":"PLoS Genet."},{"key":"31130_CR35","doi-asserted-by":"crossref","unstructured":"Liu, Q. et al. IL-33-mediated IL-13 secretion by ST2+ Treg controls inflammation after lung injury. JCI Insight 4, e123919 (2019).","DOI":"10.1172\/jci.insight.123919"},{"key":"31130_CR36","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.ymeth.2015.06.021","volume":"85","author":"A Scialdone","year":"2015","unstructured":"Scialdone, A. et al. Computational assignment of cell-cycle stage from single-cell transcriptome data. Methods 85, 54\u201361 (2015).","journal-title":"Methods"},{"key":"31130_CR37","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.coi.2013.01.003","volume":"25","author":"MG Constantinides","year":"2013","unstructured":"Constantinides, M. G. & Bendelac, A. Transcriptional regulation of the NKT cell lineage. Curr. Opin. Immunol. 25, 161\u2013167 (2013).","journal-title":"Curr. Opin. Immunol."},{"key":"31130_CR38","doi-asserted-by":"publisher","first-page":"394","DOI":"10.2165\/00063030-199707050-00007","volume":"7","author":"S Noble","year":"1997","unstructured":"Noble, S. & Goa, K. L. Aldesleukin (Recombinant Interleukin-2). Biodrugs 7, 394\u2013422 (1997).","journal-title":"Biodrugs"},{"key":"31130_CR39","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.jaut.2014.10.002","volume":"56","author":"C Bell","year":"2015","unstructured":"Bell, C. et al. Sustained in vivo signaling by long-lived IL-2 induces prolonged increases of regulatory T cells. J. Autoimmun. 56, 66\u201380 (2015).","journal-title":"J. Autoimmun."},{"key":"31130_CR40","first-page":"669","volume":"2","author":"NJ Meropol","year":"1996","unstructured":"Meropol, N. J. et al. Daily subcutaneous injection of low-dose interleukin 2 expands natural killer cells in vivo without significant toxicity. Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res. 2, 669\u2013677 (1996).","journal-title":"Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res."},{"key":"31130_CR41","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.3389\/fimmu.2019.01889","volume":"10","author":"I Pacella","year":"2019","unstructured":"Pacella, I. & Piconese, S. Immunometabolic checkpoints of Treg dynamics: Adaptation to microenvironmental opportunities and challenges. Front. Immunol. 10, 1889 (2019).","journal-title":"Front. Immunol."},{"key":"31130_CR42","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1038\/nature12297","volume":"499","author":"H Zeng","year":"2013","unstructured":"Zeng, H. et al. mTORC1 couples immune signals and metabolic programming to establish Treg-cell function. Nature 499, 485\u2013490 (2013).","journal-title":"Nature"},{"key":"31130_CR43","doi-asserted-by":"publisher","first-page":"e89160","DOI":"10.1172\/jci.insight.89160","volume":"2","author":"D Howie","year":"2017","unstructured":"Howie, D. et al. Foxp3 drives oxidative phosphorylation and protection from lipotoxicity. JCI Insight 2, e89160 (2017).","journal-title":"JCI Insight"},{"key":"31130_CR44","doi-asserted-by":"publisher","first-page":"2839","DOI":"10.3389\/fimmu.2019.02839","volume":"10","author":"RWM Kempkes","year":"2019","unstructured":"Kempkes, R. W. M., Joosten, I., Koenen, H. J. P. M. & He, X. Metabolic pathways involved in regulatory T cell functionality. Front. Immunol. 10, 2839 (2019).","journal-title":"Front. Immunol."},{"key":"31130_CR45","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1038\/s41586-018-0846-z","volume":"565","author":"SE Weinberg","year":"2019","unstructured":"Weinberg, S. E. et al. Mitochondrial complex III is essential for suppressive function of regulatory T cells. Nature 565, 495\u2013499 (2019).","journal-title":"Nature"},{"key":"31130_CR46","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1038\/ni.3577","volume":"17","author":"VA Gerriets","year":"2016","unstructured":"Gerriets, V. A. et al. Foxp3 and Toll-like receptor signaling balance Treg cell anabolic metabolism for suppression. Nat. Immunol. 17, 1459\u20131466 (2016).","journal-title":"Nat. Immunol."},{"key":"31130_CR47","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.celrep.2019.03.029","volume":"27","author":"J Miska","year":"2019","unstructured":"Miska, J. et al. HIF-1\u03b1 is a metabolic switch between glycolytic-driven migration and oxidative phosphorylation-driven immunosuppression of Tregs in glioblastoma. Cell Rep. 27, 226\u2013237.e4 (2019).","journal-title":"Cell Rep."},{"key":"31130_CR48","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1038\/nri.2016.4","volume":"16","author":"C Cekic","year":"2016","unstructured":"Cekic, C. & Linden, J. Purinergic regulation of the immune system. Nat. Rev. Immunol. 16, 177\u2013192 (2016).","journal-title":"Nat. Rev. Immunol."},{"key":"31130_CR49","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.it.2016.04.009","volume":"37","author":"MC Takenaka","year":"2016","unstructured":"Takenaka, M. C., Robson, S. & Quintana, F. J. Regulation of the T cell response by CD39. Trends Immunol. 37, 427\u2013439 (2016).","journal-title":"Trends Immunol."},{"key":"31130_CR50","doi-asserted-by":"publisher","first-page":"304","DOI":"10.3389\/fimmu.2014.00304","volume":"5","author":"A Ohta","year":"2014","unstructured":"Ohta, A. & Sitkovsky, M. Extracellular adenosine-mediated modulation of regulatory T cells. Front. Immunol. 5, 304 (2014).","journal-title":"Front. Immunol."},{"key":"31130_CR51","doi-asserted-by":"publisher","first-page":"1536","DOI":"10.3389\/fimmu.2018.01536","volume":"9","author":"MM Xie","year":"2018","unstructured":"Xie, M. M. & Dent, A. L. Unexpected help: Follicular regulatory T cells in the germinal center. Front. Immunol. 9, 1536 (2018).","journal-title":"Front. Immunol."},{"key":"31130_CR52","doi-asserted-by":"publisher","first-page":"eaan4767","DOI":"10.1126\/sciimmunol.aan4767","volume":"2","author":"BJ Laidlaw","year":"2017","unstructured":"Laidlaw, B. J. et al. Interleukin-10 from CD4+ follicular regulatory T cells promotes the germinal center response. Sci. Immunol. 2, eaan4767 (2017).","journal-title":"Sci. Immunol."},{"key":"31130_CR53","doi-asserted-by":"publisher","first-page":"E6400","DOI":"10.1073\/pnas.1705551114","volume":"114","author":"JB Wing","year":"2017","unstructured":"Wing, J. B. et al. A distinct subpopulation of CD25\u2212 T-follicular regulatory cells localizes in the germinal centers. Proc. Natl Acad. Sci. USA 114, E6400\u2013E6409 (2017).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"31130_CR54","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1038\/ni.3837","volume":"18","author":"D Botta","year":"2017","unstructured":"Botta, D. et al. Dynamic regulation of T follicular regulatory cell responses by interleukin 2 during influenza infection. Nat. Immunol. 18, 1249\u20131260 (2017).","journal-title":"Nat. Immunol."},{"key":"31130_CR55","doi-asserted-by":"publisher","first-page":"e201900520","DOI":"10.26508\/lsa.201900520","volume":"3","author":"DR Lu","year":"2020","unstructured":"Lu, D. R. et al. Dynamic changes in the regulatory T-cell heterogeneity and function by murine IL-2 mutein. Life Sci. Alliance 3, e201900520 (2020).","journal-title":"Life Sci. Alliance"},{"key":"31130_CR56","doi-asserted-by":"crossref","unstructured":"Hemmers, S., Schizas, M. & Rudensky, A. Y. T reg cell-intrinsic requirements for ST2 signaling in health and neuroinflammation. J. Exp. Med. 218, e20201234 (2020).","DOI":"10.1084\/jem.20201234"},{"key":"31130_CR57","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1038\/nature13577","volume":"513","author":"C Schiering","year":"2014","unstructured":"Schiering, C. et al. The alarmin IL-33 promotes regulatory T-cell function in the intestine. Nature 513, 564\u2013568 (2014).","journal-title":"Nature"},{"key":"31130_CR58","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.immuni.2019.12.002","volume":"52","author":"M Delacher","year":"2020","unstructured":"Delacher, M. et al. Precursors for nonlymphoid-tissue Treg cells reside in secondary lymphoid organs and are programmed by the transcription factor BATF. Immunity 52, 295\u2013312.e11 (2020).","journal-title":"Immunity"},{"key":"31130_CR59","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.3389\/fimmu.2020.01106","volume":"11","author":"A Ghelani","year":"2020","unstructured":"Ghelani, A. et al. Defining the threshold IL-2 signal required for induction of selective Treg cell responses using engineered IL-2 muteins. Front. Immunol. 11, 1106 (2020).","journal-title":"Front. Immunol."},{"key":"31130_CR60","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/S1074-7613(03)00268-1","volume":"19","author":"M Asmal","year":"2003","unstructured":"Asmal, M. et al. Production of ribosome components in effector CD4+ T cells is accelerated by TCR stimulation and coordinated by ERK-MAPK. Immunity 19, 535\u2013548 (2003).","journal-title":"Immunity"},{"key":"31130_CR61","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1038\/s41590-021-00910-8","volume":"22","author":"D Zemmour","year":"2021","unstructured":"Zemmour, D. et al. Single-cell analysis of FOXP3 deficiencies in humans and mice unmasks intrinsic and extrinsic CD4+ T cell perturbations. Nat. Immunol. 22, 607\u2013619 (2021).","journal-title":"Nat. Immunol."},{"key":"31130_CR62","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1016\/S0140-6736(20)30167-7","volume":"395","author":"B Sawitzki","year":"2020","unstructured":"Sawitzki, B. et al. Regulatory cell therapy in kidney transplantation (The ONE Study): A harmonised design and analysis of seven non-randomised, single-arm, phase 1\/2A trials. Lancet 395, 1627\u20131639 (2020).","journal-title":"Lancet"},{"key":"31130_CR63","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1242\/dmm.015099","volume":"7","author":"DE Smilek","year":"2014","unstructured":"Smilek, D. E., Ehlers, M. R. & Nepom, G. T. Restoring the balance: Immunotherapeutic combinations for autoimmune disease. Dis. Model Mech. 7, 503\u2013513 (2014).","journal-title":"Dis. Model Mech."},{"key":"31130_CR64","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.cell.2020.03.007","volume":"181","author":"L Fugger","year":"2020","unstructured":"Fugger, L., Jensen, L. T. & Rossjohn, J. Challenges, progress, and prospects of developing therapies to treat autoimmune diseases. Cell 181, 63\u201380 (2020).","journal-title":"Cell"},{"key":"31130_CR65","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1038\/s41573-020-0081-9","volume":"19","author":"NM Edner","year":"2020","unstructured":"Edner, N. M., Carlesso, G., Rush, J. S. & Walker, L. S. K. Targeting co-stimulatory molecules in autoimmune disease. Nat. Rev. Drug Discov. 19, 860\u2013883 (2020).","journal-title":"Nat. Rev. Drug Discov."},{"key":"31130_CR66","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1126\/science.1117893","volume":"310","author":"X Wang","year":"2005","unstructured":"Wang, X., Rickert, M. & Garcia, K. C. Structure of the quaternary complex of interleukin-2 with its alpha, beta, and gammac receptors. Science 310, 1159\u20131163 (2005).","journal-title":"Science"},{"key":"31130_CR67","doi-asserted-by":"publisher","first-page":"2788","DOI":"10.1073\/pnas.0511161103","volume":"103","author":"DJ Stauber","year":"2006","unstructured":"Stauber, D. J., Debler, E. W., Horton, P. A., Smith, K. A. & Wilson, I. A. Crystal structure of the IL-2 signaling complex: Paradigm for a heterotrimeric cytokine receptor. Proc. Natl Acad. Sci. USA 103, 2788\u20132793 (2006).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"31130_CR68","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1093\/protein\/gzg111","volume":"16","author":"BM Rao","year":"2003","unstructured":"Rao, B. M., Girvin, A. T., Ciardelli, T., Lauffenburger, D. A. & Wittrup, K. D. Interleukin\u20102 mutants with enhanced \u03b1\u2010receptor subunit binding affinity. Protein Eng. Des. Sel. 16, 1081\u20131087 (2003).","journal-title":"Protein Eng. Des. Sel."},{"key":"31130_CR69","doi-asserted-by":"publisher","first-page":"eaaz6893","DOI":"10.1126\/sciadv.aaz6893","volume":"6","author":"J Nelson","year":"2020","unstructured":"Nelson, J. et al. Impact of mRNA chemistry and manufacturing process on innate immune activation. Sci. Adv. 6, eaaz6893 (2020).","journal-title":"Sci. Adv."},{"key":"31130_CR70","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2018.03.010","author":"S Sabnis","year":"2018","unstructured":"Sabnis, S. et al. A novel amino lipid series for mRNA delivery: Improved endosomal escape and sustained pharmacology and safety in non-human primates. Mol. Ther. https:\/\/doi.org\/10.1016\/j.ymthe.2018.03.010 (2018).","journal-title":"Mol. Ther."},{"key":"31130_CR71","doi-asserted-by":"publisher","first-page":"4472","DOI":"10.1093\/bioinformatics\/btz279","volume":"35","author":"P Melsted","year":"2019","unstructured":"Melsted, P., Ntranos, V. & Pachter, L. The barcode, UMI, set format and BUStools. Bioinformatics 35, 4472\u20134473 (2019).","journal-title":"Bioinformatics"},{"key":"31130_CR72","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1038\/s41592-019-0654-x","volume":"17","author":"RA Amezquita","year":"2020","unstructured":"Amezquita, R. A. et al. Orchestrating single-cell analysis with Bioconductor. Nat. Methods 17, 137\u2013145 (2020).","journal-title":"Nat. Methods"},{"key":"31130_CR73","unstructured":"R Development Core Team (2019). R: A Language and Environment for Statistical Computing (R Foundation for Statistical Computing, 2019)."},{"key":"31130_CR74","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1038\/nmeth.3252","volume":"12","author":"W Huber","year":"2015","unstructured":"Huber, W. et al. Orchestrating high-throughput genomic analysis with bioconductor. Nat. Methods 12, 115\u2013121 (2015).","journal-title":"Nat. Methods"},{"key":"31130_CR75","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-017-1382-0","volume":"19","author":"FA Wolf","year":"2018","unstructured":"Wolf, F. A., Angerer, P. & Theis, F. J. SCANPY: large-scale single-cell gene expression data analysis. Genome Biol. 19, 15 (2018).","journal-title":"Genome Biol."},{"key":"31130_CR76","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-019-1662-y","volume":"20","author":"ATL Lun","year":"2019","unstructured":"Lun, A. T. L. et al. EmptyDrops: Distinguishing cells from empty droplets in droplet-based single-cell RNA sequencing data. Genome Biol. 20, 63 (2019).","journal-title":"Genome Biol."},{"key":"31130_CR77","first-page":"993","volume":"3","author":"DM Blei","year":"2003","unstructured":"Blei, D. M., Ng, A. Y. & Jordan, M. I. Latent Dirichlet allocation. J. Mach. Learn. Res. 3, 993\u20131022 (2003).","journal-title":"J. Mach. Learn. Res."},{"key":"31130_CR78","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1093\/genetics\/155.2.945","volume":"155","author":"JK Pritchard","year":"2000","unstructured":"Pritchard, J. K., Stephens, M. & Donnelly, P. Inference of population structure using multilocus genotype data. Genetics 155, 945\u2013959 (2000).","journal-title":"Genetics"},{"key":"31130_CR79","unstructured":"Erosheva, E. A. Latent class representation of the Grade of Membership model. https:\/\/citeseerx.ist.psu.edu\/viewdoc\/download?doi=10.1.1.435.2354&rep=rep1&type=pdf (2006)."},{"key":"31130_CR80","doi-asserted-by":"crossref","unstructured":"Carbonetto, P., Luo, K., Dey, K., Hsiao, J. & Stephens, M. fastTopics: fast algorithms for fitting topic models and non-negative matrix factorizations to count data. R package version 0.4-11. https:\/\/github.com\/stephenslab\/fastTopics (2021).","DOI":"10.32614\/CRAN.package.fastTopics"},{"key":"31130_CR81","doi-asserted-by":"publisher","first-page":"4288","DOI":"10.1093\/nar\/gks042","volume":"40","author":"DJ McCarthy","year":"2012","unstructured":"McCarthy, D. J., Chen, Y. & Smyth, G. K. Differential expression analysis of multifactor RNA-Seq experiments with respect to biological variation. Nucleic Acids Res. 40, 4288\u20134297 (2012).","journal-title":"Nucleic Acids Res."},{"key":"31130_CR82","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-016-0947-7","volume":"17","author":"ATL Lun","year":"2016","unstructured":"Lun, A. T. L., Bach, K. & Marioni, J. C. Pooling across cells to normalize single-cell RNA sequencing data with many zero counts. Genome Biol. 17, 75 (2016).","journal-title":"Genome Biol."},{"key":"31130_CR83","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian, A. et al. Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl Acad. Sci. USA 102, 15545\u201315550 (2005).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"31130_CR84","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.cels.2015.12.004","volume":"1","author":"A Liberzon","year":"2015","unstructured":"Liberzon, A. et al. The molecular signatures database hallmark gene set collection. Cell Syst. 1, 417\u2013425 (2015).","journal-title":"Cell Syst."},{"key":"31130_CR85","doi-asserted-by":"publisher","unstructured":"Korotkevich, G. et al. Fast gene set enrichment analysis. Preprint at bioRxiv https:\/\/doi.org\/10.1101\/060012 (2021).","DOI":"10.1101\/060012"},{"key":"31130_CR86","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1093\/bioinformatics\/btp616","volume":"26","author":"MD Robinson","year":"2010","unstructured":"Robinson, M. D., McCarthy, D. J. & Smyth, G. K. edgeR: A Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics 26, 139\u2013140 (2010).","journal-title":"Bioinformatics"},{"key":"31130_CR87","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-19894-4","volume":"11","author":"HL Crowell","year":"2020","unstructured":"Crowell, H. L. et al. muscat detects subpopulation-specific state transitions from multi-sample multi-condition single-cell transcriptomics data. Nat. Commun. 11, 6077 (2020).","journal-title":"Nat. Commun."},{"key":"31130_CR88","doi-asserted-by":"publisher","unstructured":"McCarthy, D. J., Campbell, K. R., Lun, A. T. L. & Wills, Q. F. Scater: Pre-processing, quality control, normalization and visualization of single-cell RNA-seq data in R. Bioinformatics https:\/\/doi.org\/10.1093\/bioinformatics\/btw777 (2017).","DOI":"10.1093\/bioinformatics\/btw777"},{"key":"31130_CR89","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2014-15-2-r29","volume":"15","author":"CW Law","year":"2014","unstructured":"Law, C. W., Chen, Y., Shi, W. & Smyth, G. K. voom: Precision weights unlock linear model analysis tools for RNA-seq read counts. Genome Biol. 15, R29 (2014).","journal-title":"Genome Biol."},{"key":"31130_CR90","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-019-1663-x","volume":"20","author":"FA Wolf","year":"2019","unstructured":"Wolf, F. A. et al. PAGA: Graph abstraction reconciles clustering with trajectory inference through a topology preserving map of single cells. Genome Biol. 20, 59 (2019).","journal-title":"Genome Biol."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-31130-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-31130-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-31130-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,28]],"date-time":"2024-09-28T09:39:37Z","timestamp":1727516377000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-31130-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,5]]},"references-count":90,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["31130"],"URL":"https:\/\/doi.org\/10.1038\/s41467-022-31130-9","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,5]]},"assertion":[{"value":"8 June 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 May 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 July 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare the following competing interests: All authors are current employees of Moderna, Inc. and have received salary and stock options as compensation for their employment.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"3866"}}